Manuel Soto Álvarez-rekin lankidetzan egindako argitalpenak (9)

2011

  1. Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: A preliminary evaluation

    Parasites and Vectors, Vol. 4, Núm. 1

2008

  1. Leishmania major infection in susceptible and resistant mice elicit a differential humoral response against a total soluble fraction and defined recombinant antigens of the parasite

    Parasitology Research, Vol. 102, Núm. 5, pp. 887-893

2007

  1. Adoptive transfer of dendritic cells pulsed with Leishmania infantum nucleosomal histones confers protection against cutaneous leishmaniosis in BALB/c mice

    Microbes and Infection, Vol. 9, Núm. 6, pp. 735-743

  2. The immunodominant T helper 2 (Th2) response elicited in BALB/c mice by the Leishmania LiP2a and LiP2b acidic ribosomal proteins cannot be reverted by strong Th1 inducers

    Clinical and Experimental Immunology, Vol. 150, Núm. 2, pp. 375-385

2006

  1. Immunohistological features of visceral leishmaniasis in BALB/c mice

    Parasite Immunology, Vol. 28, Núm. 5, pp. 173-183

2005

  1. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice

    Infection and Immunity, Vol. 73, Núm. 9, pp. 5842-5852

2004

  1. Recent advances in vaccines for leishmaniasis

    Expert Opinion on Biological Therapy, Vol. 4, Núm. 9, pp. 1505-1517

  2. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis

    Vaccine, Vol. 22, Núm. 29-30, pp. 3865-3876

2003

  1. The Leishmania infantum Acidic Ribosomal Protein P0 Administered as a DNA Vaccine Confers Protective Immunity to Leishmania major Infection in BALB/c Mice

    Infection and Immunity, Vol. 71, Núm. 11, pp. 6562-6572